Abstract 1765: YL413: A novel dual-payload anti-HER2 antibody-drug conjugate demonstrating potent preclinical activity
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Hanwen Deng, Tao Wang, Wei Lian, Tingting Mao, Qing Zong, Chun Deng, Bingsong Xie, Tongtong Xue, Jiaqiang Cai
Institution: MediLink Therapeutics (Suzhou) Co., Ltd. (China)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148747140
Cites:
Cited by:
Related to: